What does this research mean for the field?

The updated TNM9 clinical nodal schema, which incorporates imaging-detected extranodal extension (iENE), provides better prognostic discrimination than the TNM8 schema for patients with HPV-positive oropharyngeal cancer, with iENE independently predicting inferior survival. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To validate whether imaging-detected extranodal extension predicts survival outcomes and confirms the utility of the updated TNM9 clinical nodal staging system in HPV-positive oropharyngeal cancer.

August 29, 2026JAMA Otolaryngology–Head & Neck Surgery

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer

View Full Paper

Ask AI

Bookmark

Authors

CFChristopher W. FlemingCleveland Clinic Florida CRC.A. ReddyCleveland Clinic SSSarah Stock

Discussion

Member takes

Implication

Randomized trial demonstrates imaging-detected extranodal extension reduces survival in HPV-positive oropharyngeal cancer, supporting updated TNM9 staging.

Key Points

To validate whether imaging-detected extranodal extension predicts survival outcomes and confirms the utility of the updated TNM9 clinical nodal staging system in HPV-positive oropharyngeal cancer.
Secondary analysis of the multicenter NRG RTOG 1016 randomized clinical trial (NCT01302834) across 182 health care centers in the US and Canada.
Two expert head and neck radiologists evaluated baseline computed tomography simulation scans of 586 patients with node-positive, p16-positive disease for imaging-detected extranodal extension (median follow-up: 4.2 years).
Survival outcomes and risk discrimination were evaluated using Kaplan-Meier analyses, multivariable Cox regression models, Akaike information criterion, and Harrell concordance statistics.
Patients with imaging-detected extranodal extension experienced significantly inferior 5-year overall survival (79.2% vs 87.0%; difference, 7.8% [95% CI, 1.2%-14.4%]) and 5-year progression-free survival (68.8% vs 80.4%; difference, 11.6% [95% CI, 4.1%-19.2%]).
Imaging-detected extranodal extension remained an independent prognostic marker on multivariable analysis for overall survival (HR, 1.63; 95% CI, 1.04-2.56) and progression-free survival (HR, 1.78; 95% CI, 1.24-2.57).
The TNM8 and TNM9 clinical nodal schemas demonstrated similar overall statistical fit (TNM8: C index, 0.73 [95% CI, 0.68-0.78]; AIC = 1109.34 vs TNM9: C index, 0.72 [95% CI, 0.67-0.77]; AIC = 1112.70).

Cite This Study

Fleming et al. (2026) studied this question.

synapsesocial.com/papers/6a92be7b8e5d7d1fc0c123e9 https://doi.org/10.1001/jamaoto.2026.0932

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial demonstrates imaging-detected extranodal extension reduces survival in HPV-positive oropharyngeal cancer, supporting updated TNM9 staging.

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider